SYSMHC00019_Wangq_161024_Costello_USA_LA3ST | 4 | Human | DRB1_0301,DRB1_1501 | ||
SYSMHC00019_Wangq_161024_Costello_USA_LA4ST | 4 | Human | DRB1_1101,DRB1_1302 | ||
SYSMHC00019_Wangq_161024_Costello_USA_LA5PB | 5 | Human | DRB1_0301,DRB1_0305 | ||
SYSMHC00019_Wangq_161024_Costello_USA_LA5SF | 5 | Human | DRB1_0301,DRB1_0305 | ||
SYSMHC00019_Wangq_161024_Costello_USA_LA5ST | 4 | Human | DRB1_0301,DRB1_0305 | ||
SYSMHC00019_Wangq_161024_Costello_USA_LA6ST | 2 | Human | DRB1_0103,DRB1_0301 | ||
SYSMHC00019_Wangq_161024_Costello_USA_LA7SF_QE | 1 | Human | DRB1_0403,DRB1_1501 | ||
SYSMHC00019_Wangq_161024_Costello_USA_LA7ST | 2 | Human | DRB1_0403,DRB1_1501 | ||
SYSMHC00019_Wangq_161024_Costello_USA_LA8SF_QE | 2 | Human | DRB1_0401,DRB1_1001 | ||
SYSMHC00019_Wangq_161024_Costello_USA_LA8ST_QE | 1 | Human | DRB1_0401,DRB1_1001 | ||
SYSMHC00019_Wangq_161024_Costello_USA_RA2SF | 5 | Human | DRB1_0101,DRB1_0401 | ||
SYSMHC00019_Wangq_161024_Costello_USA_RA2ST_QE | 1 | Human | DRB1_0101,DRB1_0401 | ||
SYSMHC00019_Wangq_161024_Costello_USA_RA3ST | 4 | Human | DRB1_0101,DRB1_0401 | ||
SYSMHC00019_Wangq_161024_Costello_USA_RA4PB | 3 | Human | DRB1_0401,DRB1_1501 | ||
SYSMHC00019_Wangq_161024_Costello_USA_RA4SF | 3 | Human | DRB1_0401,DRB1_1501 | ||
SYSMHC00019_Wangq_161024_Costello_USA_RA5ST | 4 | Human | DRB1_0801,DRB1_1501 |
SYSMHC00019 | SYSMHC00019_Wangq_161024_Costello_USA_LA6ST | SYSMHC00019_LA6ST_2_Orbitrap.raw | in vivo | Lyme arthritis | disease duration .83 year | class II | 27726376 | native | Immunoaffinity | L243 | Orbitrap XL | Waters noAcquity UPLC | no | DDA | CID | Buffer A contained 1% acetonitrile (ACN) and 0.1% formic acid in water, and buffer B contained 1% water and 0.1% formic acid in ACN. | 52 min | .5 uL/min | 1 | |||||
SYSMHC00019 | SYSMHC00019_Wangq_161024_Costello_USA_LA6ST | SYSMHC00019_LA6ST_1_Orbitrap.raw | in vivo | Lyme arthritis | disease duration .83 year | class II | 27726376 | native | Immunoaffinity | L243 | Orbitrap XL | Waters noAcquity UPLC | no | DDA | CID | Buffer A contained 1% acetonitrile (ACN) and 0.1% formic acid in water, and buffer B contained 1% water and 0.1% formic acid in ACN. | 52 min | .5 uL/min | 2 |